The invention provides methods for reducing blood homocysteine levels in mammals, and treating or preventing diseases associated with elevated blood homocysteine levels, such as cardiovascular diseases and cognitive disorders. The invention also provides nutritional and pharmaceutical compositions comprising 2-hydroxy-4-(thiomethyl)-butanoic acid, including esters, analogs, derivatives or complex thereof.